Clinical Presentation and Outcomes of Phaeochromocytomas/Paragangliomas in Neurofibromatosis Type 1

Introduction: Patients with neurofibromatosis type 1 (NF1) are at risk of developing phaeochromocytomas/paragangliomas (PHAEO/PG). Unlike in other familial PHAEO/PG syndromes, there are no published guidelines regarding screening in asymptomatic or normotensive patients with NF1. This strategy may b...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Eur Endocrinol
Glavni autori: Al-Sharefi, Ahmed, Javaid, Usman, Perros, Petros, Ealing, John, Truran, Peter, Nag, Sath, Kamaruddin, Shafie, Abouglila, Kamal, Cains, Fiona, Lewis, Lauren, James, Robert Andrew
Format: Artigo
Jezik:Inglês
Izdano: Touch Medical Media 2019
Teme:
Neuroendocrine Tumours
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6785954/
https://ncbi.nlm.nih.gov/pubmed/31616500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17925/EE.2019.15.2.95
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items